Article
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.
Cancer - 15 Dec 2014
Kemeny Nancy E, Chou Joanne F, Capanu Marinela, Gewirtz Alexandra N, Cercek Andrea, Kingham T Peter, Jarnagin William R, Fong Yuman C, DeMatteo Ronald P, Allen Peter J, Shia Jinru, Ang Celina, Vakiani Efsevia, D'Angelica Michael I
Abstract excerpt
BACKGROUND: The validity of the KRAS mutation as a predictor of recurrence-free survival (RFS) or overall survival (OS) is unclear. The current study investigated whether the presence of the KRAS mutation decreased RFS or OS in patients with colorectal cancer who underwent liver resection. METHODS: Patients with resected colorectal liver metastases who received adjuvant hepatic arterial infusion plus systemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
